Faculty

Wael ElMaraachli, MD
Director, Non-CF Bronchiectasis and NTM Lung Infection Program
Associate Clinical Professor, Medicine
University of California, San Diego
San Diego, California

Disclosures:
Nothing to disclose

Planning Committee

B. Shoshana Zha, MD, PhD
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine
Director, Bronchiectasis and Pulmonary NTM Clinical Program
University of California-San Francisco
San Francisco, California 

Disclosures:
Insmed, Inc.  |  Advisory Meeting
Insmed, Inc.  |  Site investigator to enroll for clinical trial
COPD Foundation  |  Site investigator to enroll participants for Bronchiectasis Research Registry
 

Asha Anandaiah, MD
Program Director, MGH/BIDMC/Harvard Pulmonary and Critical Care Fellowship
Assistant Professor of Medicine, Harvard Medical School
Division of Pulmonary, Critical Care and Sleep Medicine
Beth Israel Deaconess Medical Center
Boston, MA 

Disclosures:
Nothing to disclose 
 

Mark L. Metersky, MD
Professor, University of Connecticut School of Medicine
Director, UCONN Center for Bronchiectasis Care
Farmington, Connecticut 

Disclosures:
Boehringer Ingelheim  |  Consultant
Tactile Systems Technology Inc  |  Consultant
AN2  |  Data And Safety Monitoring
Renovion  |  Data And Safety Monitoring
Insmed, Inc  |  Consultant

Disclosure Declaration

It is the policy of the ATS to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. As an accredited CME provider, the ATS requires that its planners, reviewers and presenters comply with the ACCME Standards Integrity and Independence in Accredited Continuing Education.  The ATS also requires specific disclosure of relationships with companies and organizations associated with tobacco or cannabis and prohibits or limits participation of faculty in official ATS activities, including CME, if any tobacco industry relationship or some types of cannabis industry relationships is present. The most recent policies regarding potential conflicts of interest as well as the mechanisms to mitigate or resolve such conflicts can be found here: COI Policy for Official ATS Activities (thoracic.org)

All relevant financial relationships have been reviewed and mitigated.
 

The section below is currently not in use